# Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

> **NCT01092611** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 190 (actual)

## Conditions studied

- AIDS

## Interventions

- **PROCEDURE:** Blood collection
- **BIOLOGICAL:** GSK HIV vaccine 732462

## Key facts

- **NCT ID:** NCT01092611
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-22
- **Primary completion:** 2014-03-17
- **Final completion:** 2014-05-19
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2018-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01092611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01092611, "Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01092611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*